ArticleBMC anesthesiology2026
Dexmedetomidine as an alternative to general anesthesia in vertebroplasty and kyphoplasty: a safety and efficacy study.
Article in BMC anesthesiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo evaluate the effectiveness and safety of dexmedetomidine during vertebroplasty and kyphoplasty surgery in patients with vertebral compression fractures due to malignancy and osteoporosis.
methodsThis retrospective study included 41 patients, comprising 22 with osteoporosis and 19 with malignant conditions. Perioperative systolic blood pressure (SBP), diastolic blood pressure (DBP), heart rate (HR), oxygen saturation (SpO2), Visual Analog Scale (VAS) scores, complications, as well as the duration of the operation and anesthesia, were recorded. Additionally, the investigators’ satisfaction scores were documented.
resultsAll parameters (SBP, DBP, HR, and SpO2) showed statistically significant temporal variations from baseline values (p < 0.001). SBP decreased significantly from the 5th minute onward, while DBP and HR exhibited significant reductions beginning at the 10th minute. These decreases, although statistically significant, were clinically expected and manageable, aligning with the known pharmacodynamic profile of dexmedetomidine. In contrast, SpO2 values demonstrated significant increases at the 15th and 30th minutes, indicating preserved respiratory stability. The median preoperative VAS score was 6 (range: 1–10), while the median score at 60 min postoperatively was 1 (range: 0–3). The median operator satisfaction score was 3 (range: 1–3).
conclusionsIn minimally invasive surgery for vertebral compression fractures, particularly in elderly patients with comorbidities, dexmedetomidine sedoanalgesia appeared to be a well-tolerated and feasible option for achieving adequate sedation and pain control. Nevertheless, due to the retrospective design and limited sample size, further prospective and controlled studies are required to confirm these findings and better define its role in clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.